CX3CR1 and neoplasm: Although MR design reduces confounding bias, we recommend future studies to: validate the microbiota–metabolite–osteosarcoma pathway in independent cohorts; analyze the spatial distribution of CX3CR1+ monocytes in the tumor microenvironment through single‐cell sequencing to verify their mediating role.